Author: Customer Service

NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) — G-III Apparel Group, Ltd. (NASDAQ: GIII) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share. The dividend is payable on March 30, 2026 to stockholders of record on March 23, 2026. About G-III Apparel Group, Ltd.  G-III Apparel Group, Ltd. is a global fashion leader with expertise in design, sourcing, distribution, and marketing. The Company owns and licenses a portfolio of more than 30 preeminent brands, each differentiated by unique brand propositions, product categories, and consumer touchpoints. G-III owns ten iconic brands, including DKNY, Donna Karan, Karl Lagerfeld, and Vilebrequin, and licenses over 20 of the most sought-after names in global fashion, including Calvin Klein, Tommy Hilfiger, Levi’s, Nautica, Halston, Champion, Converse,...

TORONTO, March 13, 2026 (GLOBE NEWSWIRE) — STORAGEVAULT CANADA INC. (“StorageVault” or the “Corporation”) (SVI-TSX announced today that a quarterly dividend of $0.003006 per common share (“Common Share”) ‎will be payable on ‎April 15, 2026 to shareholders of record on March 31, 2026, with an ex-dividend ‎date of March 31, 2026. This dividend has been designated as an “eligible dividend” for Canadian ‎income tax ‎purposes.‎ ‎ About StorageVault Canada Inc.StorageVault currently owns and operates 265 storage locations across Canada. StorageVault owns 232 of these locations plus over 5,000 portable storage units representing over 13.2 million rentable square feet on 768 acres of land. StorageVault also provides last mile storage and logistics’ solutions and professional records management services, ‎such as document and media storage,...

Segment showcases SynCardia Total Artificial Heart supporting patients with advanced heart failure and next-generation development programs TUCSON, Ariz., March 13, 2026 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that the SynCardia Total Artificial Heart (“STAH”) will be featured in an upcoming segment on BTV Business Television airing on the FOX Business News on Saturday, March 14 at 5:00 p.m. EST. The segment will highlight the Company artificial heart technology designed to replace the pumping function of a failing human heart during the time that a patient awaits transplantation. With more than 2,100 implants performed worldwide, the STAH...

NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) — AMC Robotics Corporation (Nasdaq: AMCI) (“AMC Robotics” or the “Company”), an AI-driven robotics solutions provider, and HIVE Digital Technologies (“HIVE”) (TSX.V: HIVE) (Nasdaq: HIVE) (FSE: YO0) (BVC: HIVECO), a global leader in sustainable digital infrastructure and AI compute, today jointly announced a strategic collaboration focused on advancing next-generation AI-driven robotics applications and scalable infrastructure capabilities. Through this collaboration, AMC Robotics has begun utilizing HIVE’s GPU AI compute infrastructure and related services to support the Company’s expanding development, testing, and deployment needs. In parallel, the two companies are actively exploring broader areas of cooperation, including potential collaboration across AI optimization, data processing,...

BROOKLYN, N.Y., March 13, 2026 (GLOBE NEWSWIRE) — Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) (“Voyager” or the “Company”) held the general meeting on March 12, 2026 and approved the previously announced business combination (the “Business Combination”) with VERAXA Biotech AG (“VERAXA”). After the closing of the Business Combination, it is expected that the combined company will trade on Nasdaq under the new symbol (“VRXA”). As previously announced, holders of 25,217,315 of the Company’s Class A ordinary shares (“Class A shares”) exercised their right to redeem their shares for a pro rata portion of the funds in the Company’s trust account, reflecting redemptions of approximately 99.67% of the total Class A shares outstanding in connection with the completion of the Business Combination pursuant...

Sanoma Corporation, Stock Exchange Release, 13 March 2026 at 11:30 a.m EET Proposals of the Shareholders’ Nomination Committee to Sanoma’s Annual General Meeting 2026 The Shareholders’ Nomination Committee of Sanoma Corporation presents the following proposals to the Annual General Meeting planned to be held on 7 May 2026. The proposals will also be included in the Notice to the Annual General Meeting planned to be published on the Company’s website at sanoma.com on 25 March 2026. Proposal of the composition of the Board of Directors The Shareholders’ Nomination Committee proposes that the number of the members of the Board of Directors is set at eight. The Nomination Committee proposes that Klaus Cawén, Julian Drinkall, Jannica Fagerholm, Rolf Grisebach, Timo Lappalainen, Sebastian Langenskiöld and Eugenie van Wiechen are re-elected as...

BEIJING, March 13, 2026 (GLOBE NEWSWIRE) — iQIYI, Inc. (Nasdaq: IQ) (“iQIYI” or the “Company”), a leading provider of online entertainment video services in China, today announced the results of its previously announced repurchase right offer relating to its 6.50% Convertible Senior Notes due 2028 (CUSIP No. G4939KAF3) (the “Notes”). The repurchase right offer expired at 5:00 p.m., New York City time, on Thursday, March 12, 2026. Based on information from Citibank, N.A. as the paying agent for the Notes (the “Paying Agent”), US$207,800,000 aggregate principal amount of the Notes were validly surrendered and not withdrawn prior to the expiration of the repurchase right offer. The aggregate amount of the repurchase price of these Notes (including the aggregate principal amount of the Notes plus accrued and unpaid interest) (the “Repurchase...

On March 12, 2026, Novonesis, through Novozymes A/S, successfully priced and closed an aggregate principal amount of EUR 1.7 billion senior unsecured notes (the “Notes”). The issuance was completed under the newly established EUR 4 billion Euro Medium Term Note (EMTN) Programme, dated March 10, 2026. The Notes will be issued on March 19, 2026, and listed on the Luxembourg Stock Exchange. This inaugural issuance consists of three tranches with maturities ranging from 4 to 11 years and fixed interest rates ranging from 3.25% to 4.00%. Novonesis has been rated A- (stable outlook) by Standard & Poor’s (S&P). The net proceeds from the transaction will be used to refinance existing debt and for general corporate purposes. For further details about the EMTN Programme and this issuance, please visit our website.Contact...